Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC7A5 | Q01650 | 3/20 | 0.96 |
| ▸ | PTGS1 | P23219 | 3/20 | 0.68 |
| ▸ | ALPI | P09923 | 1/20 | 0.68 |
| ▸ | PKM | P14618 | 1/20 | 0.68 |
| ▸ | XIAP | P98170 | 1/20 | 0.68 |
| ▸ | ALOX15 | P16050 | 3/20 | 0.62 |
| ▸ | HIF1A | Q16665 | 3/20 | 0.62 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.62 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.62 |
| ▸ | USP2 | O75604 | 1/20 | 0.62 |
| ▸ | EGFR | P00533 | 1/20 | 0.62 |
| ▸ | LCK | P06239 | 1/20 | 0.62 |
| ▸ | FYN | P06241 | 1/20 | 0.62 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.62 |
| ▸ | HTR2A | P28223 | 1/20 | 0.62 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.62 |
| ▸ | RECQL | P46063 | 1/20 | 0.62 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.62 |
| ▸ | TPH1 | P17752 | 1/20 | 0.57 |
| ▸ | GRB2 | P62993 | 1/20 | 0.57 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Tyrosine SCHEMBL8505607 | 1.00 | SLC7A5 (0.96) | SLC7A5PTGS1ALPIPKMXIAP | |
| Tyrosine SCHEMBL1122928 | 1.00 | SLC7A5 (0.96) | SLC7A5PTGS1ALPIPKMXIAP | |
| Tyrosine SCHEMBL17010331 | 0.98 | SLC7A5 (0.92) | SLC7A5PTGS1ALPIPKMXIAP | |
| Tyrosine SCHEMBL17010327 | 0.98 | SLC7A5 (0.92) | SLC7A5PTGS1ALPIPKMXIAP | |
| Tyrosine SCHEMBL638520 | 0.98 | SLC7A5 (1.00) | SLC7A5PTGS1ALPIPKMXIAP | |
| Tyrosine SCHEMBL1580 | 0.98 | SLC7A5 (1.00) | SLC7A5PTGS1ALPIPKMXIAP | |
| Tyrosine SCHEMBL11520041 | 0.98 | SLC7A5 (1.00) | SLC7A5PTGS1ALPIPKMXIAP | |
| Tyrosine SCHEMBL1581 | 0.98 | SLC7A5 (1.00) | SLC7A5PTGS1ALPIPKMXIAP | |
| Tyrosine SCHEMBL11676395 | 0.98 | SLC7A5 (1.00) | SLC7A5PTGS1ALPIPKMXIAP | |
| Tyrosine SCHEMBL11676367 | 0.98 | SLC7A5 (1.00) | SLC7A5PTGS1ALPIPKMXIAP |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 264 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119781262-A | Compatible high-definition resist stripping liquid composition | 杭州格林达电子材料股份有限公司 | 2025-04-08 | — | — | CN | claimed |
| EP-3333261-B1 | HEXURONATE C4-EPIMERASE VARIANT WITH IMPROVED D-TAGATOSE PRODUCTION ACTIVITY, AND D-TAGATOSE PRODUCTION METHOD USING SAME | CJ CHEILJEDANG CORP (KR) | 2023-11-15 | — | — | EP | claimed |
| EP-3911354-B1 | AAV-MEDIATED GENE THERAPY RESTORING THE OTOFERLIN GENE | PASTEUR INSTITUT (FR) | 2023-07-19 | — | — | EP | claimed |
| EP-3710594-B1 | METHODS TO MEASURE FUNCTIONAL HETEROGENEITY AMONG SINGLE CELLS | UNIV COLORADO REGENTS (US) | 2023-07-19 | — | — | EP | claimed |
| US-20230105024-A1 | Bifunctional C-Glycoside Glycosyltransferases and Application Thereof | CAS CENTER FOR EXCELLENCE IN MOLECULAR PLANT SCIENCES (CN) | 2023-04-06 | — | — | US | claimed |
| US-20230066984-A1 | New Carbon Glycoside Glycosyltransferase and Use Thereof | CAS CENTER FOR EXCELLENCE IN MOLECULAR PLANT SCIENCES (CN) | 2023-03-02 | — | — | US | claimed |
| EP-4108777-A1 | BIFUNCTIONAL C-GLYCOSIDE GLYCOSYLTRANSFERASES AND APPLICATION THEREOF | CAS Center for Excellence in Molecular Plant Sciences (CN) | 2022-12-28 | — | — | EP | claimed |
| US-20220033786-A1 | PROVISION OF MALONYL-COA IN CORYNEFORM BACTERIA AND METHOD FOR PRODUCING POLYPHENOLES AND POLYKETIDES WITH CORYNEFORM BACTERIA | FORSCHUNGSZENTRUM JUELICH GMBH (DE) | 2022-02-03 | — | — | US | claimed |
| US-11230721-B2 | Production of a flavour compound in a host cell | AXXENCE AROMATIC GMBH (DE) | 2022-01-25 | — | — | US | claimed |
| EP-3928787-A1 | ENGINEERED TYROSINE AMMONIA LYASE | Codexis, Inc. (US) | 2021-12-29 | — | — | EP | claimed |
| WO-2005103273-A1 | MICROBIAL PRODUCTION OF AROMATIC ACIDS | NEDERLANDSE ORGANISATIE VOOR TOEGEPAST- NATUURWETENSCHAPPELIJK ONDERZOEK TNO (NL) | 2005-11-03 | — | — | WO | claimed |
| EP-0948345-B1 | PHARMACEUTICAL COMPOSITION CONTAINING AN INHIBITOR OF IMMUNOGLOBULIN-RECEPTOR INTERACTION | TECNOGEN SCPA (IT) | 2002-09-25 | — | — | EP | claimed |
| EP-0828002-B1 | Modification of xylanase to improve thermophilicity, alkophilicity and thermostability | CA NAT RESEARCH COUNCIL (CA) | 2002-04-17 | — | — | EP | claimed |
| EP-0721586-B1 | METHODS AND COMPOSITIONS FOR TREATMENT OF BCR-ABL ASSOCIATED LEUKEMIAS AND OTHER CELL PROLIFERATIVE DISORDERS | UNIV NEW YORK MEDICAL CT (US) | 2001-05-30 | — | — | EP | claimed |
| EP-0977855-A2 | POLYPEPTIDES ASSOCIATED WITH ACTIVATOR RECEPTORS AND THEIR BIOLOGICAL APPLICATIONS | INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM) (FR) | 2000-02-09 | — | — | EP | claimed |
| WO-1998049292-A2 | POLYPEPTIDES ASSOCIATED WITH ACTIVATOR RECEPTORS AND THEIR BIOLOGICAL APPLICATIONS | INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM) (FR) | 1998-11-05 | — | — | WO | claimed |
| EP-0804484-A1 | ANTIGENIC POLYPEPTIDE SEQUENCE OF FACTOR VIII, FRAGMENTS AND/OR EPITOPES THEREOF | CROIX ROUGE DE BELGIQUE (BE) | 1997-11-05 | — | — | EP | claimed |
| WO-1996002572-A2 | ANTIGENIC POLYPEPTIDE SEQUENCE OF FACTOR VIII, FRAGMENTS AND/OR EPITOPES THEREOF | CROIX-ROUGE DE BELGIQUE (BE) | 1996-02-01 | — | — | WO | claimed |
| EP-0375040-B1 | Process for the preparation of retro-inverso peptides and new intermediates thereof | SCLAVO SPA (IT) | 1994-03-16 | — | — | EP | claimed |
| EP-0134631-B1 | PEPTIDES, PHARMACEUTICAL COMPOSITIONS, GENES, VECTORS, HOST ORGANISMS, PROCESSES FOR THEIR PRODUCTION AND DIAGNOSTIC REAGENTS | CELLTECH LIMITED (GB) | 1991-04-03 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230066984-A1 | New Carbon Glycoside Glycosyltransferase and Use Thereof | UGGT1, UGDH, UGCG | SLC7A5 1880/4885PTGS1 3126/4885ALPI 3043/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.